Bayer reaches Roundup settlement that could cost the company billions
Key Points:
- Bayer has agreed to a nationwide settlement potentially costing up to $7.25 billion to compensate thousands of people who allege that exposure to its weed-killer Roundup caused their non-Hodgkin lymphoma.
- Compensation amounts will range from $10,000 to $165,000, depending on factors such as exposure level, occupation, and age at diagnosis.
- The settlement was approved by a Missouri judge and described as one of the largest mass tort personal-injury class action settlements in history.
- Bayer denies that Roundup causes cancer, despite the World Health Organization classifying glyphosate as probably carcinogenic and ongoing scientific debate; the EPA currently does not see risks but is reviewing the evidence.
- This settlement follows a previous $10-11 billion payout by Bayer to resolve over 100,000 Roundup-related claims, and comes amid political and regulatory controversies surrounding glyphosate in the U.S.